Skip to content

IMAX Corp

US · IMAX #2528 by market cap Listed 2011
51.45 +0.87 +1.72%
Live - 5344 symbols - heartbeat 60s ago · 2026-10-07 20:28
After-hours 51.45 0.00%
Overnight 51.45 0.00%
Market cap
2.82B
P/B
7.93
EPS
0.63
Reader sentiment Are you bullish or bearish on IMAX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • Total institutional ownership fell 0.6 percentage points.

Institutional ownership

Held by institutions
100.10% -0.57pp
Institutions
310
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund82.40%
Individual/Insider18.34%
Hedge Fund6.78%
Sovereign Wealth Fund5.24%
Public Company3.79%
Government Pension Fund1.01%
Private Company0.52%
Insurance Company0.27%
Family Office/Trust0.10%

Top holders as of 2026-06-11

Kevin Douglas 13.72% · 7.52M sh
Orbis Investment Management Limited 9.39% · 5.15M sh
Macquarie Investment Management Business Trust 5.35% · 2.94M sh
BlackRock 5.30% · 2.91M sh
GIC Private Limited 5.23% · 2.87M sh
Westfield Capital Management Company, L.P. 4.84% · 2.65M sh
Congress Asset Management Company, LLP 4.63% · 2.54M sh
Driehaus Capital Management LLC 4.27% · 2.34M sh
FMR 4.23% · 2.32M sh
Columbia Management Investment Advisers, LLC 3.23% · 1.77M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 20 buys · 30 sells

NameRoleStake
Kevin Douglas Independent Director 13.72%
Richard Gelfond Chief Executive Officer 1.21%
Robert Lister Chief Legal Officer & Senior EVP 0.33%
Mark Welton President of Imax Theatres 0.26%
David Leebron Lead Independent Director 0.24%
Dana Settle Independent Director 0.13%
Pablo Calamera Executive Vice President 0.08%
Giovanni Dolci Chief Sales Officer 0.07%
Michael I. MacMillan Independent Director 0.07%
Eric Demirian Independent Director 0.07%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-14 Giovanni Dolci Chief Sales Officer Other Derivative Acquisition +2,578 --
2026-09-09 Robert Lister Chief Legal Officer & Senior EVP Open Market Disposition -22,500 $51.58
2026-08-24 Mark Welton President of Imax Theatres Open Market Disposition -30,000 $54.47
2026-08-24 Kenneth Weissman Deputy General Counsel & Corporate Secretary Open Market Disposition -8,000 $54.54
2026-08-23 Natasha Fernandes Chief Financial Officer Open Market Disposition -20,000 $54.63
2026-08-19 Richard Gelfond Chief Executive Officer Open Market Disposition -100,000 $53.23
2026-08-19 Pablo Calamera Executive Vice President Open Market Disposition -15,000 $52.41
2026-08-18 Richard Gelfond Chief Executive Officer Derivative Exercise and Sale -356,757 $31.90–53.27
2026-08-18 Richard Gelfond Chief Executive Officer Intent to Sell (Form 144) -205,504 $53.71
2026-08-17 Richard Gelfond Chief Executive Officer Intent to Sell (Form 144) -151,253 $50.55
2026-08-05 Jose Zlatar Senior VP of Finance & Principal Accounting Officer Open Market Disposition -500 $49.90
2026-06-10 Dana Settle Independent Director Other Derivative Acquisition +3,390 --
2026-06-10 Dana Settle Independent Director Derivative Exercise and Retained +3,390 --
2026-06-10 Michael I. MacMillan Independent Director Derivative Exercise and Sale -1,849 $42.12
2026-06-10 Michael I. MacMillan Independent Director Other Derivative Acquisition +3,390 --
2026-06-10 Michael I. MacMillan Independent Director Derivative Exercise and Retained +1,541 --
2026-06-10 Eric Demirian Independent Director Derivative Exercise and Sale -1,842 $42.12
2026-06-10 Eric Demirian Independent Director Other Derivative Acquisition +3,390 --
2026-06-10 Eric Demirian Independent Director Derivative Exercise and Retained +1,548 --
2026-06-10 Kevin Douglas Independent Director Other Acquisition +3,390 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 20:28:12 · For reference only, not investment advice and not tailored to your situation.